All FDA Regulated Industry

$199.00
Sample Reanalysis

 April 22 2025
 11 : 00 AM EST    
 60 Minutes
Sample Reanalysis

Sample re-analysis may be required for numerous reasons. Assay failure is the most common and the clearest. Individual re-analysis is usually justified by the lack of internal standards or the failure to meet chromatographic parameters such as retention time or peak shape. In ligand binding assays and chromatographic assays, the color or peak height may exceed expectations or fall below expectations. These&..

$199.00
Navigating the Complexities of Newer Technologies When Validating FDA-Regulated Systems

 May 05 2025
 03 : 00 PM EST    
 90 Minutes
Navigating the Complexities of Newer Technologies When Validating FDA-Regulated Systems

Advancements in technology have forced companies to rethink business models. Once controlled and orderly, these organizations are now more chaotic and complex, serving patients and customers that are better informed and have higher expectations than ever before. Work practices and tools must change to meet these challenges.The approach to developing software, performing validation, and maintaining a system ..

$199.00
Effective Technical Writing for FDA Submissions

 May 08 2025
 01 : 00 PM EST    
 90 Minutes
Effective Technical Writing for FDA Submissions

Technical Writing for FDA Submissions is a critical skill for professionals in regulated industries, including pharmaceuticals, medical devices, and biotechnology. Regulatory submissions to the U.S. Food and Drug Administration (FDA) must be clear, precise, and well-structured to ensure compliance and facilitate regulatory review. Poorly written submissions can lead to delays, requests for additional inform..

$199.00
FDA 483 or Warning Letter? Now what?

 May 09 2025
 01 : 00 PM EST    
 90 Minutes
FDA 483 or Warning Letter? Now what?

The training on “FDA 483 or Warning Letter – Now What?” is designed to empower professionals in FDA-regulated industries with the knowledge and skills necessary to respond effectively to regulatory challenges. FDA 483 observations and Warning Letters signify potential non-compliance issues that require immediate attention to avoid escalated enforcement actions. This webinar provides a comprehensive roadmap ..

$199.00
Holding Vendors Accountable through Robust Contracts and Service Level Agreements (SLA) for Products and Services Used in FDA-Regulated Operations

 May 12 2025
 03 : 00 PM EST    
 90 Minutes
Holding Vendors Accountable through Robust Contracts and Service Level Agreements (SLA) for Products and Services Used in FDA-Regulated Operations

In this webinar, the attendees will learn about the many best practices that will lead to a better and sounder contract and SLA. It does not require a lot of effort but must be done with diligence.Computer systems that are used in FDA-regulated environments (i.e., the system “touches” an FDA-regulated product or a raw material or packaging component used in conjunction with the product during the manuf..

$199.00
Applying Six Sigma "Downtime" in the Bioanalytical Lab

 May 20 2025
 11 : 00 AM EST    
 60 Minutes
Applying Six Sigma "Downtime" in the Bioanalytical Lab

Applies the consideration of the acronym "DOWNTIME" to improve function and efficiency in the LAB. - Defects- reduce or eliminate - Overproduction reduces waste of materials, time, and personnel - Waiting to eliminate waiting on resource access or permission - Non-utilized resources- instruments, personnel - Transportation-movement (temporal or spatial) of resources/or documents&nbs..

$199.00
The Human Error Toolbox: A Practical Approach to Human Error

 May 21 2025
 01 : 00 PM EST    
 90 Minutes
The Human Error Toolbox: A Practical Approach to Human Error

Human error is known to be the primary cause of quality and production losses in many industries. Although human error is unlikely to ever be eliminated, many human performance problems can be prevented. Human errors start at the design stage. From procedures, training, and workplace environment, many variables that affect human behavior can be managed, reducing the likelihood of these occurrences. When wor..

$200.00
21 CFR Part 11 and Annex 11 Compliance; specifics needed to eliminate 483s when using SaaS/Cloud

 May 27 2025
 01 : 00 PM EST    
 90 Minutes
21 CFR Part 11 and Annex 11 Compliance; specifics needed to eliminate 483s when using SaaS/Cloud

This webinar describes exactly what is required for compliance with Computer Software Assurance guidance, 21 CFR Part 11, and the European equivalent Annex 11 for local and SaaS/Cloud-hosted applications. It explains how to write a Data Privacy Statement for compliance with the EU General Data Protection Regulation (GDPR). What the regulations mean is described for all four primary compliance areas: SOPs, s..

$199.00
Unlocking Manufacturing Effectiveness: Practical Strategies for Overcoming Production Constraints

 May 28 2025
 01 : 00 PM EST    
 60 Minutes
Unlocking Manufacturing Effectiveness: Practical Strategies for Overcoming Production Constraints

In today’s fast-paced manufacturing environment, being busy doesn’t always translate to being productive. Operations that appear smooth on the surface may in fact be stagnant—or even declining—in terms of output. The hidden culprit is often an overlooked constraint or bottleneck quietly limiting the entire system’s performance.In this session, industry expert José Ignacio Mora shares a practical approach in..

$199.00
Computer System Validation (CSV) Boot Camp

 August 08 2025
 03 : 00 PM EST    
 90 Minutes
Computer System Validation (CSV) Boot Camp

We will explore the best practices and strategic approach for evaluating computer systems used in the conduct FDA-regulated activities and determining the level of potential risk, should they fail, on data integrity, process and product quality, and consumer/patient safety. We will walk through the System Development Life Cycle (SDLC) approach to validation, based on risk assessment, and will also discuss 2..

$200.00
21 CFR Part 11 (Electronic Records/Signatures) Compliance for Computer Systems Regulated by FDA

 Recorded Webinar
 90 Minutes
 Refer a Friend
21 CFR Part 11 (Electronic Records/Signatures) Compliance for Computer Systems Regulated by FDA

The Webinar will focus on the importance of ensuring that electronic record/electronic signature (ER/ES) capability built into FDA-regulated computer systems meets compliance with 21 CFR Part 11. This includes development of a company philosophy and approach, and incorporating it into the overall computer system validation program and plans for individual systems that have this capability.Areas CoveredCompu..

$200.00
5 Key Components of Good Manufacturing Practices to obtain cGMP certification

 Recorded Webinar
 60 Minutes
 Refer a Friend
5 Key Components of Good Manufacturing Practices to obtain cGMP certification

Pharmaceutical and other FDA-regulated industries are tasked with safely manufacturing products for people (or animals) around the world. The FDA has set specific requirements, known as cGMPs) for facilities to meet the standards for a product to be deemed safe, pure, and effective. Good Manufacturing Practices are critical to any organization that produces products for the public. This training will discus..

$200.00
Analytical Method Validation and Transfer

 Recorded Webinar
 90 Minutes
 Refer a Friend
Analytical Method Validation and Transfer

This course provides guidance on how to perform QC analytical test method validations and transfers. One of the most critical factors in developing and marketing pharmaceutical drug substances and drug products is ensuring that the analytical methods used for analysis can generate valid data upon which business and regulatory decisions can be made. FDA, ICH and USP have each recognized the importance of thi..

$200.00
Basic Validation Statistics for Non - Statisticians

 Recorded Webinar
 60 Minutes
 Refer a Friend
Basic Validation Statistics for Non - Statisticians

In this program, we will discuss the common statistics tools and techniques used in validation. Through real world examples and interactive exercises, we will demonstrate the basic concepts of statistics and how to apply them to your validation projects. Discussion will center around measures of variance, sample distributions, and expressions of variance. The session will conclude with a discussion of the c..

$200.00
Best Practices for Responding to a Form 483 Citation and/or Warning Letter Issued by FDA

 Recorded Webinar
 90 Minutes
 Refer a Friend
Best Practices for Responding to a Form 483 Citation and/or Warning Letter Issued by FDA

FDA has substantial authority to oversee regulated companies and their operations. The primary purpose of FDA is to assure safe and effective products that will protect public health. Violations can have seriously adverse effects on products, and ultimately, on patients and consumers.The root of every company’s effort to defend its practices and products is through data and documentation, meaning both struc..

Showing -179 to -165 of 124 (9 Pages)